SANTORO, RAFFAELA
 Distribuzione geografica
Continente #
NA - Nord America 550
EU - Europa 419
AS - Asia 187
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 1.162
Nazione #
US - Stati Uniti d'America 550
CN - Cina 169
GB - Regno Unito 113
IT - Italia 83
DE - Germania 66
IE - Irlanda 48
SE - Svezia 47
FR - Francia 29
FI - Finlandia 15
UA - Ucraina 10
BE - Belgio 5
VN - Vietnam 5
KR - Corea 4
AU - Australia 2
EU - Europa 2
IN - India 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
ID - Indonesia 1
IR - Iran 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
PE - Perù 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 1.162
Città #
Chandler 149
Southend 110
Ashburn 91
Dublin 48
Jacksonville 36
Beijing 31
Verona 30
Woodbridge 30
Jinan 22
Ann Arbor 14
Lawrence 14
Princeton 14
Tianjin 14
Wilmington 13
Helsinki 12
Hebei 10
New York 10
Haikou 9
Shenyang 9
Taiyuan 9
Washington 8
Changsha 7
Houston 6
Jiaxing 6
Nanjing 6
Redmond 6
Zhengzhou 6
Brussels 5
Ningbo 5
Nürnberg 5
Redwood City 5
Hangzhou 4
Nanchang 4
Seattle 4
Bologna 3
Chicago 3
Fairfield 3
Lanzhou 3
Seoul 3
Sindelfingen 3
Taizhou 3
Dearborn 2
Des Moines 2
Dong Ket 2
Fuzhou 2
Giugliano In Campania 2
Guangzhou 2
Lancaster 2
Milan 2
Monza 2
Almaty 1
Baku 1
Bratislava 1
Canberra 1
Centurion 1
Chaoyang 1
Düsseldorf 1
Fremont 1
Gurgaon 1
Hanoi 1
Lima 1
Melbourne 1
Munich 1
Nocera Inferiore 1
Oklahoma City 1
Paese 1
Phnom Penh 1
Pozza 1
Quartu Sant'elena 1
Riga 1
Riyadh 1
Roverbella 1
San Diego 1
San Francisco 1
Selargius 1
Stockholm 1
Tirana 1
Xiangfen 1
Yerevan 1
Zanjan 1
Totale 821
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 196
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 127
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 100
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 90
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance 90
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 80
Modulating TAK1 expression inhibits YAP and TAZ oncogenic functions in pancreatic cancer 71
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer 69
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer 66
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer 63
Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation 62
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 61
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity 58
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy 55
Totale 1.188
Categoria #
all - tutte 3.448
article - articoli 3.448
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.896


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 2 5
2019/2020131 10 1 5 6 16 13 19 8 14 9 13 17
2020/2021172 15 15 12 27 15 16 2 0 11 44 11 4
2021/2022156 11 64 3 8 0 2 1 9 3 3 8 44
2022/2023333 19 46 26 56 25 90 1 24 35 6 3 2
2023/2024192 4 13 20 16 20 44 24 38 2 11 0 0
Totale 1.188